• Aadi Bioscience: Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting More
• AffaMed Therapeutics: Completion of Patient Enrollment in the Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA in Cataract Surgery Patients More
• Arcutis: Leadership Transition More
• A2 Bio: First Patient Dosed in Phase 1 Clinical Trial of A2B530, a Novel Cell Therapy for the Treatment of Colorectal, Pancreatic and Non-Small Cell Lung Cancers More
• Be The Match BioTherapies: Will Provide Robust Cell Therapy Infrastructure to Support Garuda Therapeutics' Potentially Ground-Breaking Off-The-Shelf Cell Therapies More
• BioXcel Therapeutics: Promising Topline Results From Part 1 of Pivotal SERENITY III Trial of BXCL501 for At-Home Use in Acute Treatment of Agitation in Bipolar Disorders or Schizophrenia More
• Clarametyx Biosciences: Changes to Its Scientific Advisory Board More
• CNS Pharmaceuticals: Achieves Over 50% Completion of Enrollment in Potentially Pivotal Study With Berubicin for the Treatment of Glioblastoma Multiforme (GBM) More
• Landos Biopharma: Expands Board of Directors With Appointment of Alka Batycky, Ph.D. More
• NellOne: Wienhold Joins More
• SpringWorks Therapeutics: Full Enrollment of Phase 2 Trial Evaluating Nirogacestat in Patients With Ovarian Granulosa Cell Tumors More
• Tvardi Therapeutics: Presentation of Data From the Phase 1 Trial of TTI-101, a STAT3 Inhibitor, in Advanced Solid Tumors at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting More
• Zentalis: Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination With Chemotherapy at the 2023 ASCO Annual Meeting More

• Custom Surgical Implant Startup Using AI Lands 96 Investors for $12M in New Cash More
• Digital Health Funding Holds Steady in Q1 After Year of Decline More
• Follow The Money: In Life Sciences, Private Cash Filling Funding Gap More*
• Landos Biopharma: 1-for-10 Reverse Stock Split More
• Ocuphire Pharma: Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) More
• PTC Therapeutics: Strategic Pipeline Prioritization More More More*
• VoluMetrix: Awarded $3 Million NIH SBIR Phase IIb Grant to Propel Development of Non-Invasive Heart Failure Monitoring, NIVA|HF More

HOT INVESTOR MANDATES from MAY 11

• Hot Investor Mandate: Investment Arm of Large Corporation Invests in Accountable Care-Centered Solutions, Targeting the USA Market More
• Hot Investor Mandate: Global Investment Firm Focusing on Oncology Therapies Invests Up to $30M Over the Company’s Lifecycle More
• Hot Investor Mandate: VC Firm With US & Asia Offices Seeks New Investments in Medical Devices, Synthetic Biology, and Digital Health More
• Hot Investor Mandate: Women-Led VC Seeks to Invest in Life Science Companies Addressing Women’s Health, Prioritizing Europe-Based Opportunities More

• Fresh From Gene-Edited Food Launch, Durham Startup Unveils CRISPR Tech Platform More
• Most Recent Tweets From BioStartup News More
• Serial Biotech Founder Tim Springer on Investing in Startups and Democratizing Antibody Research More
• The 20(+2) Under 40: Your Guide to the Next Generation of Biotech Leaders More*
• Your Amazing Startup Idea Isn't Taking Off? Here's Why More

• US Life Science Startup Company Directory More

• BIO International Convention June 4 - 8
• NEHEN Fundraising During a Challenging Economic Environment June 5
• RESI Boston June 5
• Bullpen Harbor Cruise at BIO June 6
• Philadelphia Life Science Update June 21
• **SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR**

• Scientist, Discovery Bioinformatics, Velia Therapeutics - San Diego, CA / Onsite / Remote More
• Vice President, Medical Lead, Relay Therapeutics - Cambridge, MA More
• Director, Clinical Quality Assurance (cQA), Neumora - Remote More
• Sr. Director Clinical Pharmacology, Mineralys - Radnor, PA More
• Validation Engineer, Forge Biologics - Columbus, OH More
• Scientist, Translational Sciences, Umoja Biopharma - Seattle, WA / Onsite / Remote More